| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |